These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28497760)

  • 1. The intestinal microbiome and paediatric liver disease.
    Leung DH; Yimlamai D
    Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):446-455. PubMed ID: 28497760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The gut microbiome is important in chronic liver disease].
    Christensen E
    Ugeskr Laeger; 2019 Jan; 181(2):. PubMed ID: 30618372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
    Boursier J; Diehl AM
    Clin Liver Dis; 2016 May; 20(2):263-75. PubMed ID: 27063268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin A and liver diseases.
    Inamine T; Schnabl B
    J Gastroenterol; 2018 Jun; 53(6):691-700. PubMed ID: 29075899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome and liver diseases.
    Tilg H; Cani PD; Mayer EA
    Gut; 2016 Dec; 65(12):2035-2044. PubMed ID: 27802157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiome & NASH - partners in crime driving progression of fatty liver disease].
    Wree A; Geisler LJ; Tacke F
    Z Gastroenterol; 2019 Jul; 57(7):871-882. PubMed ID: 31288283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal microbiota and nonalcoholic steatohepatitis.
    Brandl K; Schnabl B
    Curr Opin Gastroenterol; 2017 May; 33(3):128-133. PubMed ID: 28257306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.
    Panasevich MR; Peppler WT; Oerther DB; Wright DC; Rector RS
    Physiol Genomics; 2017 Aug; 49(8):385-399. PubMed ID: 28600319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outside the liver box: The gut microbiota as pivotal modulator of liver diseases.
    Wahlström A
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):912-919. PubMed ID: 31007175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease.
    Koukias N; Buzzetti E; Tsochatzis EA
    Minerva Endocrinol; 2017 Jun; 42(2):184-194. PubMed ID: 27879962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota.
    Cahova M; Bratova M; Wohl P
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28880224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the gut microbiota in the pathology and prevention of liver disease.
    Altamirano-Barrera A; Uribe M; Chávez-Tapia NC; Nuño-Lámbarri N
    J Nutr Biochem; 2018 Oct; 60():1-8. PubMed ID: 29653359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
    Brandl K; Schnabl B
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
    Chopyk DM; Grakoui A
    Gastroenterology; 2020 Sep; 159(3):849-863. PubMed ID: 32569766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gut microbiota in liver disease.
    Albhaisi SAM; Bajaj JS; Sanyal AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.
    Iwasawa K; Suda W; Tsunoda T; Oikawa-Kawamoto M; Umetsu S; Inui A; Fujisawa T; Morita H; Sogo T; Hattori M
    Gut; 2017 Jul; 66(7):1344-1346. PubMed ID: 27670376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.